Tag Archive for 'Exenatide' | Sci.News

ANCOVA (analysis of covariance) comparing decline in DaTscan (electrocardiographic and single photon emission CT) binding between the placebo and exenatide groups: (A) placebo group: reduced DaTscan binding in the left caudate, right caudate, and left putamen; (B) exenatide group: reduced DaTscan binding in the left caudate and right caudate; (C) significant clusters derived from the first level of analysis used to do an ANCOVA between placebo and exenatide groups showing a reduced rate of decline in the right caudate, left putamen, and right putamen. Image credit: Athauda et al, doi: 10.1016/S0140-6736(17)31585-4.

Diabetes Drug Exenatide Shows Promise against Parkinson’s Disease

Aug 7, 2017 by News Staff

Exenatide, a drug commonly used to treat Type 2 diabetes, may have disease-modifying potential to treat Parkinson’s disease, according to new research...